Medical cannabis in this week’s analysis!
Aksjeanalyser.com takes a closer look at a Danish company!
Stenocare A/S
(ticker on First North Denmark: STENO)
The technical picture for Stencare is positive and indicates a potential for the share to more than double in the next 3-6 months. Read more about this below in the technical analysis.
About the company Stenocare A/S
(ticker on First North Denmark: STENO)
Stenocare A/S is engaged in the cultivation, production, and distribution of medical cannabis products. The company offers medical cannabis oils, which include cannabidiol drops, tetrahydrocannabinol drops, and blends of CBD and THC oils. The company was founded by Thomas Skovlund-Schnegelsberg, Soren Kjaer, and Rolf Steno-Peterson on October 19, 2017, and is headquartered in Randers, Denmark.
For more information about the company, visit their website here.
Technical Analysis of Stenocare A/S
(ticker on First North Denmark: STENO)
The overall technical picture is very positive for Stenocare, and the stock shows a strong development within a rising trend that started around May 2025 (see day and weekly chart below).
The stock has had a correction down in the short term, and is now finding significant technical support both down towards the 50-day moving average and around the DKK 1.50 – 1.60 level.
Furthermore, the share is in the process of breaking out of the long-term downward trend that the share has been moving within since 2019 (see weekly chart above).
At the same time as the stock has now corrected down towards a significant technical support level, and at the lower trend line in the rising trend. Both the RSI and Stochastic momentum indicators are now signaling that a new upward turn for the stock may be imminent.
The BEST model in Vikingen is also in a buy signal for the Stenocare stock. This popular and effective technical analysis model was developed by Peter Östevik. He finalized the BEST model around 2019, and after 30 years of experience in technical analysis and Vikingen Financial Software.
Based on the overall positive technical picture that Stenocare shows, Aksjeanalyser.com finds the stock to be a very exciting and interesting buy candidate around the current price level.
The potential for the share is considered to be up to the DKK 4.00 level in as short a time as the next 3-6 months.
What could possibly change the currently positive technical picture that the Stenocare share is currently showing would be if it were to have an established break below the 50-day moving average and below the DKK 1.50 level.
Don’t miss Börssnack and the training courses via Aktieutbildning.nu!
Every week you have the opportunity to participate in Börssnack, which Aktieutbildning.nu gives on Wednesdays, via an open webinar at 19.00-20.00 CET! Here you will find more information about Börssnack.
In Börssnack you’ll learn how to invest in interesting companies and get answers to questions like:
How do we make better deals on the stock market? Which global stock markets look the best? How should you act in the stock market? Is it time to buy/sell now? Which stocks and funds are interesting? What does Börssnack’s portfolio look like? It is reviewed and analyzed every Wednesday.
In addition, we offer Aktieutbildning.nu offers several valuable training courses. The start course is completely free!
Vikingen Financial Software reminds you that past positive results do not always indicate future profits and that all trading is at your own risk.
Sincerely yours
